Back to top
more

Hologic (HOLX)

(Delayed Data from NSDQ)

$75.02 USD

75.02
1,449,518

+0.07 (0.09%)

Updated May 17, 2024 04:00 PM ET

After-Market: $75.00 -0.02 (-0.03%) 7:12 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (91 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Baxter Launches Drug Library Guide for Smart Infusion System

Baxter International Inc. (BAX) recently introduced an infusion system drug library guide to help clinicians identify potential errors in the infusion process during intravenous treatment.

    Intuitive Surgical: Q1 Solid, Procedures Likely to Slow Ddown

    On Apr 21, we issued an updated research report on Sunnyvale-based Intuitive Surgical (ISRG) -- manufacturer of the da Vinci surgical system (an advanced robot-assisted surgical system) and related instruments and accessories.

      Quest Diagnostics (DGX) Tops Q1 Earnings, Raises '17 View

      Quest Diagnostics' (DGX) first-quarter 2017 adjusted earnings per share (EPS) of $1.33 came in 13.7% ahead of the Zacks Consensus Estimate.

        Abbott (ABT) Tops Q1 Earnings on Strong EPD, Medical Device

        Abbott Laboratories (ABT) reported first-quarter 2017 adjusted earnings from continuing operations of 48 cents per share, up 17.1% year over year.

          Intuitive Surgical (ISRG) Beats on Q1 Earnings & Revenues

          Intuitive Surgical Inc.(ISRG) posted adjusted earnings of $4.67 per share in the first quarter of 2017, crushing the Zacks Consensus Estimate of $3.97 on stellar revenue growth.

            Mazor (MZOR) Gets FDA Clearance For Mazor X Align Software

            Mazor Robotics Ltd. (MZOR), recently announced that it has received the FDA clearance for its Mazor X Align software.

              Quality Systems (QSII) to Acquire Entrada for $34 Million

              Quality Systems, Inc. announced that it has entered into a deal to acquire Entrada, Inc. for $34 million.

                Mazor Robotics (MZOR) Catches Eye: Stock Moves Up 10.2%

                Mazor Robotics Ltd. (MZOR) moved big last session, as its shares rose over 10% on the day.

                  Hologic (HOLX) Up 3.9% Since Earnings Report: Can It Continue?

                  Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                    Allscripts' (MDRX) dbMotion Solution Available Through Azure

                    Allscripts Healthcare Solutions, Inc. (MDRX), announced that dbMotion Solution will be now available through Microsoft Corporation's (MSFT) cloud computing service Azure.

                      Accuray TomoTherapy System Starts Cancer Treatment in Africa

                      Accuray Inc. (ARAY) recently announced that the Radiotherapy and Medical Oncology Center of Sidi Abdellah, Algeria has finally initiated cancer treatment with the company's flagship TomoTherapy system.

                        ResMed's Study Results for Central Sleep Apnea Hold Promise

                        ResMed Inc. (RMD) recently sponsored a study which shows potential treatment of obstructive sleep apnea (OSA) in patients with untreated central sleep apnea (CSA).

                          athenahealth (ATHN) Allies with CoverMyMeds for Faster ePA

                          athenahealth Inc. (ATHN) recently entered into a strategic partnership with CoverMyMeds.

                            DaVita Banks on Acquisitions, Escalating Expenses a Concern

                            On Apr 10, we issued an updated research report Denver, CO-based DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure.

                              Masimo (MASI) Launches Root Platform with Kite Trademark

                              Irvine, CA-based Masimo Corporation (MASI) announced full market release of the Root monitoring platform with a Kite trademark (a supplementary display system).

                                AngioDynamics (ANGO) Prices 2.5M Secondary Share Offering

                                AngioDynamics, Inc. (ANGO) announced that it has priced its underwritten public offering of 2.35 million shares of common stock.

                                  ABIOMED (ABMD) Banks on Impella Platform, Forex a Concern

                                  On Apr 7, we issued an updated research report on Danvers, MA-based ABIOMED, Inc. (ABMD), a leading medical product developer.

                                    Hill-Rom's Innovations Make Surgeries More Safe, Accurate

                                    Hill-Rom Holdings, Inc. (HRC) recently demonstrated the impact of surgical patient positioning on skin and nerve pressure-related injuries.

                                      PetMed Faces Concerns over New Order Sales, Competition

                                      On Apr 6, we issued an updated research report on Pompano Beach, FL-based PetMed Express, Inc. (PETS).

                                        athenahealth Now a Strong Buy: Should You Add the Stock?

                                        On Apr 5, athenahealth (ATHN) was raised to a Zacks Rank #1 (Strong Buy).

                                          Medidata & TESARO Win CARE 'Clinical Partnership' Award

                                          Medidata Solutions Inc. (MDSO) recently announced the receipt of the 'Clinical Partnership of the Year' award at the second annual Clinical and Research Excellence (CARE) Awards, courtesy of its 'unique technology collaboration' with TESARO.

                                            Omnicell's Aesynt Buyout Looks Promising amid Several Woes

                                            On Apr 6, we issued an updated research report on Mountain View, CA-based Omnicell Inc. (OMCL).

                                              David Bartosiak headshot

                                              Crude Bucks Choppy Trend - Dave's Daily Dive

                                              Crude bucked the choppy trend in markets today as equities sloshed back-and-forth most of the day

                                                Tirthankar Chakraborty headshot

                                                New Strong Buy Stocks for April 4th

                                                Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday

                                                  Hologic Completes Cynosure Buyout, Boosts Core Business

                                                  Hologic, Inc. (HOLX) recently announced the completion of it earlier declared acquisition of marketer of aesthetic treatment systems, Cynosure, Inc.